Ludwig, MD, PhD Harvard Medical School After 15 years of research in partnership with experts from Stanford and UCLA, we developed BuildLeaf as a safer, more effective evolution of Tirzepatide
Cold intolerance is not listed among the common adverse effects in the Summary of Product Characteristics for semaglutide (Wegovy) or liraglutide (Saxenda), which typically include gastrointestinal symptoms (nausea, vomiting, diarrhoea, constipation), injection site reactions, and headache
These positive effects were observed when an SGLT2i was added to a GLP1RA, when a GLP1RA was added to an SGLT2i (71), or when the initial combination was compared to each individual therapy (72)
Protein, resistance training, sleep, and a reasonable calorie deficit matter most
GLP-1 medications like Ozempic and Wegovy help protect heart health, but stopping the medications may reduce the protective effects